ConductScience.org, home

Paper39796183

Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness.

Gambacurta A and 5 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness. Papers, record 39796183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39796183

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.45, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gambacurta AAlessandra
2Tullio VValentinahttps://orcid.org/0000-0002-4109-1805
3Savini IIsabellahttps://orcid.org/0000-0002-3667-1557
4Mauriello AAlessandrohttps://orcid.org/0000-0002-7351-5676
5Catani MVMaria Valeriahttps://orcid.org/0000-0002-7088-9242
6Gasperi VValeriahttps://orcid.org/0000-0003-3200-8093

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Breast NeoplasmsMajor topic
Kruppel-Like Transcription FactorsMajor topic
Trans-ActivatorsMajor topic
CarcinogenesisMajor topic
Neoplastic Stem CellsMajor topic
Humans
Female
Gene Expression Regulation, Neoplastic
Proto-Oncogene Mas
Cell Line, Tumor
Proto-Oncogene Protein c-ets-2

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2007KAWXCL_002Italian Ministry of ResearchPubMed
0000147/2022Tor Vergata University of RomePubMed
Progetto cellule staminaliNAST CentrePubMed
PNC-E3-2022-23683266 PNCHLS-DA projectDiagnostica AvanzataPubMed

Source PubMed

Download CSV of grants

References98

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132410348miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells.J Cell Mol Med2020https://conductscience.org/library/papers/32410348PubMed
220708002Dysregulation of microRNAs in cancer: playing with fire.FEBS Lett2011https://conductscience.org/library/papers/20708002PubMed
332858223hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets.Genomics Proteomics Bioinformatics2020https://conductscience.org/library/papers/32858223PubMed
424368110miR-126 in human cancers: clinical roles and current perspectives.Exp Mol Pathol2014https://conductscience.org/library/papers/24368110PubMed
524996968The clinicopathological significance of neurogenesis in breast cancer.BMC Cancer2014https://conductscience.org/library/papers/24996968PubMed
629778234EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer.Cancer Genet2018https://conductscience.org/library/papers/29778234PubMed
729327503Noncoding RNAs in Alzheimer's disease.Wiley Interdiscip Rev RNA2018https://conductscience.org/library/papers/29327503PubMed
823900443Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.Oncol Rep2013https://conductscience.org/library/papers/23900443PubMed
919116145Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.Biochem Biophys Res Commun2009https://conductscience.org/library/papers/19116145PubMed
1023102669MicroRNA and cancer.Mol Oncol2012https://conductscience.org/library/papers/23102669PubMed
1131665654Polyunsaturated fatty acids modulate the delivery of platelet microvesicle-derived microRNAs into human breast cancer cell lines.J Nutr Biochem2019https://conductscience.org/library/papers/31665654PubMed
1232424275Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.Nat Cell Biol2020https://conductscience.org/library/papers/32424275PubMed
1326463235Methylation of the miR-126 gene associated with glioma progression.Fam Cancer2016https://conductscience.org/library/papers/26463235PubMed
1435328298miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer.Diagnostics (Basel)2022https://conductscience.org/library/papers/35328298PubMed
1533468253Neural stemness contributes to cell tumorigenicity.Cell Biosci2021https://conductscience.org/library/papers/33468253PubMed
1619493678Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.Eur J Cancer2009https://conductscience.org/library/papers/19493678PubMed
1720619534miR-126 functions as a tumour suppressor in human gastric cancer.Cancer Lett2010https://conductscience.org/library/papers/20619534PubMed
1819047084Cancer-related axonogenesis and neurogenesis in prostate cancer.Clin Cancer Res2008https://conductscience.org/library/papers/19047084PubMed
1936091786Emerging role of different DNA methyltransferases in the pathogenesis of cancer.Front Pharmacol2022https://conductscience.org/library/papers/36091786PubMed
2020671229Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells.Arterioscler Thromb Vasc Biol2010https://conductscience.org/library/papers/20671229PubMed

See all 98 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41154638Bioinformatics Strategies in Breast Cancer Research.Biomolecules2025https://conductscience.org/library/papers/41154638PubMed
41011238The Role of Non-Coding Regions in Breast Cancer: From Gene Regulation to Therapeutic Implications.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41011238PubMed
40149447The Emerging Role of MicroRNAs in Nasal Inflammatory Diseases and Tumors: From Bench to Bedside.Genes (Basel)2025https://conductscience.org/library/papers/40149447PubMed
40141248Decoding the Epigenome of Breast Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40141248PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
EBF11879PubTator's text mininghttps://conductscience.org/library/genes/1879NCBI Gene
ETS22114PubTator's text mininghttps://conductscience.org/library/genes/2114NCBI Gene
KLF210365PubTator's text mininghttps://conductscience.org/library/genes/10365NCBI Gene
MIR126406913PubTator's text mininghttps://conductscience.org/library/genes/406913NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39796183

GET https://conductscience.org/api/papers/v1/39796183/references?page=2